Safetussin PM is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Kramer Laboratories. The primary component is Dextromethorphan; Doxylamine Succinate.
| Product ID | 55505-173_4361fc39-6bc7-4fde-866d-471d4c88f41f |
| NDC | 55505-173 |
| Product Type | Human Otc Drug |
| Proprietary Name | Safetussin PM |
| Generic Name | Dextromethorphan Doxylamine Succinate |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-02-09 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Kramer Laboratories |
| Substance Name | DEXTROMETHORPHAN; DOXYLAMINE SUCCINATE |
| Active Ingredient Strength | 8 mg/5mL; mg/5mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2017-02-09 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-02-09 |
| Ingredient | Strength |
|---|---|
| DEXTROMETHORPHAN | 7.5 mg/5mL |
| SPL SET ID: | 0f7e2c22-0c59-4027-ad61-6bdd048a605c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0295-5307 | Safetussin | Dextromethorphan Doxylamine Succinate |
| 55505-173 | Safetussin | Dextromethorphan Doxylamine Succinate |
| 55505-190 | Safetussin | Dextromethorphan Doxylamine Succinate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SAFETUSSIN 78592800 3068103 Live/Registered |
Kramer Laboratories, Inc. 2005-03-22 |